Colinz Laboratories Ltd — Quarterly Results & Earnings

₹44.50

+0.00%

Profit Growth YoY-12.50%Latest quarter

Sales Growth YoY-25.27%Latest quarter

Sales CAGR 5Y-2.81%5 year compound

Profit CAGR 5Y30.92%5 year compound

📋

Quarterly Performance

YoY Profit Growth-12.50%

🔴 Significant decline

YoY Sales Growth-25.27%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

7.65%

EPS Growth 5Y

30.92%

Interest Coverage

Higher = safer debt servicing

12.80

ROE

5.43%

ROCE

6.72%

💡

Growth Analysis

Colinz Laboratories Ltd reported YoY profit growth of -12.50% and revenue growth of -25.27% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -2.81% and profits at 30.92% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Colinz Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.